Skip to main content

FDA-Cleared TreatmentsCovered by Most InsurancePhysician-Led Care

TMS vs Ketamine: Which Is Right for Treatment-Resistant Depression?

TMS is a non-drug treatment that stimulates the brain with magnetic pulses and builds gradually. Ketamine is a medication, used off-label for depression, that can act quickly but often needs repeated dosing. A physician-led clinic that offers both can explain the trade-offs. Most major insurance plans are accepted for TMS.

Watch: TMS vs Ketamine: Which Is Right for Treatment-Resistant Depression?

TMS vs Ketamine: Which Is Right for Treatment-Resistant Depression?

When depression has not responded to medication, two treatments tend to come up in the same breath: TMS and ketamine. Choosing between them starts with recognizing how differently they work. If you are comparing options in Denver or elsewhere in Colorado, this guide lays out the differences in plain terms.

How TMS works

Transcranial magnetic stimulation is a non-drug treatment. Magnetic pulses stimulate a region of the prefrontal cortex, delivered on weekdays over several weeks. Nothing enters the body, you stay alert throughout, and the effect builds gradually. You can read the full overview on our TMS therapy page.

TMS is FDA-cleared for major depressive disorder and for obsessive-compulsive disorder.

How ketamine works

Ketamine is a medication. Used for depression, it is off-label, meaning that it is prescribed for a purpose other than the one for which it has formal FDA labeling. It is delivered under physician supervision by infusion, injection, lozenge or nasal spray, and it acts on the brain's glutamate system in a way that differs from conventional antidepressants.

Its effect, when it occurs, can appear quickly, sometimes after the first few sessions. That speed is part of its appeal for people in acute distress. Our overview of ketamine therapy covers how supervised treatment is structured.

The trade-offs

Ketamine has drawbacks that are worth stating plainly.

  • Durability. The benefit often fades without repeated dosing.
  • The session itself. Each session involves a dissociative experience, followed by a monitoring period and then a ride home.
  • Cost structure. Ketamine therapy is generally self-pay.

TMS has its own trade-offs. It asks for a commitment of time on weekdays across several weeks, and its effect builds gradually rather than arriving quickly. TMS gains often hold for months after a course without ongoing dosing, but TMS does not help everyone, and a psychiatrist will say so plainly.

A related option: SPRAVATO

SPRAVATO is an esketamine nasal spray. It is FDA-approved for treatment-resistant depression in adults, and it is given in a certified setting with monitoring. Most major insurance plans are accepted for it. It is not the same as compounded or off-label ketamine, and it follows a defined clinical pathway. Our page on SPRAVATO explains how that works.

How does a psychiatrist choose between them?

There is no single rule. Several factors point in different directions, and an evaluation weighs all of them.

Urgency

Someone in a severe episode may be steered toward a faster-acting option first. If you are in distress right now, say so at the start of the evaluation, because it changes the order in which options are considered.

Durability

TMS gains often hold for months after a course without ongoing dosing. Ketamine's benefit, by contrast, often fades without repeated dosing. If you want something that does not require ongoing maintenance, that difference matters.

Medical history

Blood pressure, substance use history and seizure risk each point in different directions. A history that makes one option less suitable may make the other more reasonable, which is why the screening is thorough.

Practicalities

Practical fit matters more than people expect. Daily weekday appointments for several weeks suit some schedules, while periodic longer sessions with a monitoring period and a ride home suit others. You can drive yourself after TMS. After ketamine, you need someone to take you home.

Coverage

What coverage criteria allow shapes the decision too. Benefits are verified before treatment begins, so you know where you stand before committing to a plan.

Sometimes it is not either-or

Sometimes the two are used in sequence, or one is tried after the other has not helped. A person who did not respond to one approach has not exhausted their options, and a person who responded to one may later consider the other. The order, timing and combination are decisions to make with a psychiatrist who knows your history.

Why a clinic that offers both matters

A clinic that offers both can lay out the trade-offs without a thumb on the scale. If a clinic provides only one treatment, it is natural for that treatment to look like the answer. When the same physician can offer TMS, SPRAVATO and supervised ketamine therapy, the conversation can focus on what fits you rather than on what is available.

The evaluation is where that conversation happens. For a deeper look at two of the options, see our comparison of SPRAVATO vs TMS.

What the first conversation looks like

An evaluation for treatment-resistant depression is not a sales conversation. It is a structured review. The psychiatrist asks how long the current episode has lasted, which medications you have taken and at what doses, how you responded, and what side effects you experienced. The goal is to work out whether earlier trials were adequate, whether anything has been overlooked, and which option fits your current situation. You can also use the appointment to ask direct questions, such as how soon you might notice a change, what a typical week of treatment looks like, and what happens if the first choice does not help.

What to bring to your evaluation

  • Your treatment history. What you have tried, for how long and what happened.
  • Your current medications. Include supplements.
  • Your priorities. Speed, durability, schedule and cost can all legitimately matter.
  • Your questions. Including anything you have read online and want clarified.

How care works at TMS Therapy Centers Colorado

TMS Therapy Centers Colorado is a physician-led psychiatric clinic founded by William Kromka, MD, a board-certified psychiatrist. The first step is an evaluation, either in person or by secure video from anywhere in Colorado, and no referral is needed. Your benefits are verified and prior authorization is handled before treatment begins, and most major insurance plans are accepted. CareCredit® financing is available. To get started, call 720-500-7873.

Ketamine used for depression is off-label. A related nasal spray, SPRAVATO (esketamine), is FDA-approved for treatment-resistant depression in adults and is given in a certified setting with monitoring. TMS, a non-drug option, is FDA-cleared for major depressive disorder. A psychiatrist can explain how each fits your history during an evaluation.